The Enteral Feeding Formulas Market is forecasted to grow from USD 6.16 Billion in 2020 to USD 10.97 Billion by 2028, at a CAGR of 7.5%, during the forecast period. The market is primarily driven by the growing geriatric population, chronic diseases, and premature births, high spending on health care and high demand for home care.

Increase in patients suffering from cardiovascular diseases, cancer and diabetes, the leading disease-causing death, has driven the enteral formula market. Continuous clinical trials show the growth of new developments in products. Another key factor that positively impacts the growth of tube feeds is the increasing number of new product launches.

The enteral tube feeding is used for the administration of nutrients through the intestine or the stomach through the tubes and this applies to those patients who are unable to meet the nutrient requirements or are unable to orally consume nutrients. Various types of tubes, such as nasojejunal tube, nasogastric tube, gastrostomy and jejunostomy, are available for enteral formula feeding.

Top Companies Profiled in the Report Include:

Fresenius Kabi AG (Germany), Victus Inc. (US), B. Braun Melsungen AG (Germany), Global Health Product Inc. (US), Abbott Laboratories (US), Nestle (Switzerland), Danone S.A. (France), Mead Johnson Nutrition Company (US), Hormel Foods, LLC (US), Meiji Holdings Co., Ltd. (Japan) and others.

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Enteral Feeding Formulas market in these key regions.

Country-wise regional analysis covers:

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • BENELUX
  • Italy
  • Spain
  • Switzerland
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East Africa
  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Turkey
  • Rest of MEA

Additionally, the report consists a detailed analysis of the segmentation of the Enteral Feeding Formulas market based on product types and end-use/application offered in the Enteral Feeding Formulas market -

Type (Revenue, USD Million; 2020-2028)

• Standard Formula
• Specialty Formula
• Blenderized Formula
• Elemental Formula
• Semi-Elemental Formula
• Polymeric Formula
• Fiber Supplemented Formula
• Others

Age (Revenue, USD Million; 2020-2028)

• Adult
• Infants

Form (Revenue, USD Million; 2020-2028)

• Powder
• Liquid
• Others

Flavor (Revenue, USD Million; 2020-2028)

• Vanilla
• Strawberry
• Butter pecan
• Unflavored

Application (Revenue, USD Million; 2020-2028)

• Oncology
• Neurology
• Diabetes
• Critical care

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.